Stock BCPC BALCHEM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Balchem Corporation

Equities

BCPC

US0576652004

Specialty Chemicals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
138.5 USD -1.52% Intraday chart for Balchem Corporation -3.23% -6.89%
Mar. 29 Balchem Corporation Announces Management Changes CI
Mar. 12 Balchem Insider Sold Shares Worth $840,985, According to a Recent SEC Filing MT

Business Summary

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Number of employees: 1,302

Sales per Business

USD in Million2022Weight2023Weight Delta
Human Nutrition and Health
59.7 %
527 55.9 % 551 59.7 % +4.48%
Animal Nutrition and Health
25.8 %
262 27.8 % 238 25.8 % -9.14%
Specialty Products
13.7 %
131 13.9 % 126 13.7 % -4.16%
Other and Unallocated
0.8 %
21 2.3 % 7 0.8 % -65.58%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
74.8 %
682 72.4 % 690 74.8 % +1.08%
Foreign Countries
25.2 %
260 27.6 % 233 25.2 % -10.49%

Managers

Managers TitleAgeSince
Theodore Harris CEO
 Chief Executive Officer 59 15-04-27
Martin Bengtsson DFI
 Director of Finance/CFO 47 19-02-03
Michael Sestrick CTO
 Chief Tech/Sci/R&D Officer 61 16-12-31
Mary Ann Brush IRC
 Investor Relations Contact - -
Jonathan Griffin PRN
 Corporate Officer/Principal - 10-12-31
Martin Reid PRN
 Corporate Officer/Principal 57 21-01-31
Hatsuki Miyata LAW
 General Counsel - 22-06-30
Brent Tignor HRO
 Human Resources Officer - 16-08-31
William Backus AUD
 Comptroller/Controller/Auditor 58 05-12-31

Members of the board

Members of the board TitleAgeSince
Daniel Knutson BRD
 Director/Board Member 67 18-01-31
Theodore Harris CEO
 Chief Executive Officer 59 15-04-27
Matthew Wineinger BRD
 Director/Board Member 57 15-09-14
Olivier Rigaud BRD
 Director/Board Member 60 23-09-05
Joyce Lee BRD
 Director/Board Member 51 19-09-11
Kathleen Fish BRD
 Director/Board Member 66 21-06-16
David Fischer BRD
 Director/Board Member 61 10-09-15
Monica Vicente BRD
 Director/Board Member 58 23-09-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,266,941 31,955,500 ( 99.03 %) 0 99.03 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
14.81 %
4,780,341 14.81 % 741 M $
Vanguard Fiduciary Trust Co.
11.75 %
3,791,512 11.75 % 587 M $
APG Asset Management NV
8.987 %
2,899,974 8.987 % 449 M $
Wasatch Advisors, Inc.
5.832 %
1,881,814 5.832 % 292 M $
STATE STREET CORPORATION
3.758 %
1,212,565 3.758 % 188 M $
Conestoga Capital Advisors LLC
3.357 %
1,083,212 3.357 % 168 M $
Geneva Capital Management LLC
2.424 %
782,094 2.424 % 121 M $
Geode Capital Management LLC
2.319 %
748,410 2.319 % 116 M $
Dimensional Fund Advisors LP
2.131 %
687,485 2.131 % 107 M $
BNY Mellon Investment Adviser, Inc.
1.843 %
594,766 1.843 % 92 M $

Company contact information

Balchem Corp.

5 Paragon Drive

07645, Montvale

+845 326 5600

http://www.balchem.com
address Balchem Corporation(BCPC)

Sector

Basic Materials
Chemicals
Chemicals
Specialty Chemicals
Other Specialty Chemicals

Sales per Business

Sales per region

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
138.5 USD
Average target price
154.8 USD
Spread / Average Target
+11.73%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
BALCHEM CORPORATION Stock Balchem Corporation
-6.89% 4.47B
ECOLAB INC. Stock Ecolab Inc.
+10.81% 62.84B
GIVAUDAN SA Stock Givaudan SA
+12.69% 39.67B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.94% 25.73B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+4.77% 18.27B
CELANESE CORPORATION Stock Celanese Corporation
-0.95% 17.17B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.87% 15.81B
SYMRISE AG Stock Symrise AG
+0.28% 14.96B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-20.42% 13.51B
NITTO DENKO CORPORATION Stock Nitto Denko Corporation
+35.55% 12.66B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. BCPC Stock
  4. Company Balchem Corporation